Tenet Healthcare Corporation $THC Shares Sold by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC reduced its stake in Tenet Healthcare Corporation (NYSE:THC) by 58.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,000 shares of the company’s stock after selling 50,000 shares during the period. Tenet Healthcare comprises approximately 2.1% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its 4th largest position. Sivik Global Healthcare LLC’s holdings in Tenet Healthcare were worth $7,106,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Boston Partners grew its stake in shares of Tenet Healthcare by 95.0% during the second quarter. Boston Partners now owns 2,267,142 shares of the company’s stock worth $398,949,000 after buying an additional 1,104,500 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after purchasing an additional 157,109 shares in the last quarter. Norges Bank acquired a new stake in shares of Tenet Healthcare during the second quarter valued at about $206,981,000. AQR Capital Management LLC increased its stake in shares of Tenet Healthcare by 28.0% in the second quarter. AQR Capital Management LLC now owns 1,156,263 shares of the company’s stock valued at $200,224,000 after buying an additional 252,993 shares during the period. Finally, Alliancebernstein L.P. raised its holdings in Tenet Healthcare by 375.7% in the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after buying an additional 624,125 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on THC shares. Mizuho upped their price target on shares of Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a research report on Friday, October 17th. Royal Bank Of Canada increased their price objective on Tenet Healthcare from $230.00 to $252.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. JPMorgan Chase & Co. lifted their price objective on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Wells Fargo & Company increased their target price on shares of Tenet Healthcare from $238.00 to $252.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Finally, UBS Group boosted their price target on shares of Tenet Healthcare from $238.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average price target of $231.81.

Tenet Healthcare Trading Up 0.6%

NYSE:THC opened at $208.18 on Wednesday. The firm has a fifty day simple moving average of $202.55 and a two-hundred day simple moving average of $189.40. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $222.82. The stock has a market capitalization of $18.30 billion, a price-to-earnings ratio of 14.27, a PEG ratio of 0.88 and a beta of 1.41. The company has a current ratio of 1.71, a quick ratio of 1.64 and a debt-to-equity ratio of 2.27.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.33 by $0.37. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The company had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter in the prior year, the firm earned $2.93 EPS. The business’s revenue was up 3.2% on a year-over-year basis. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. Analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Insider Transactions at Tenet Healthcare

In related news, insider R. Scott Ramsey sold 13,322 shares of the stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $205.11, for a total value of $2,732,475.42. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Nadja West sold 2,178 shares of the business’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the sale, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This trade represents a 7.10% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 45,500 shares of company stock valued at $9,247,071 over the last ninety days. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.